0 Comments
0 Shares
98 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Strategic Projections: Assessing the Multi-Billion Dollar Future of Biological Follow-onsThe financial community is keeping a watchful eye on the biotechnology sector as it prepares for a surge in biosimilar approvals. The complexity of manufacturing these drugs serves as a high barrier to entry, ensuring that only the most sophisticated pharmaceutical firms can compete. This has led to a market dominated by players who can manage intricate supply chains and navigate the...0 Comments 0 Shares 199 Views 0 Reviews
-
The "PD-1 Patent Cliff" Countdown: How 2026 is Preparing for the Next Big Wave.In late 2026, the industry is pivoting toward "Immuno-Oncology (IO) Preparation." This year, a radical new wave of R&D is focused on the impending 2028 patent expirations of blockbuster PD-1 inhibitors like Keytruda and Opdivo. This innovation is a primary driver for the market, as these "Checkpoint Inhibitors" currently represent the largest segment of oncology spending worldwide. Using...0 Comments 0 Shares 209 Views 0 Reviews